Accession Number: | 0001127602-21-023101 |
Date: | 2021-08-02 |
Issuer: | MEDTRONIC PLC (MDT) |
Original Submission Date: |
LERMAN BRADLEY E
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2021-08-02 | S | 4,000 | d | $131.52 | 48,194 | direct | ||
ORDINARY SHARES | 2021-08-02 | F | 5,450 | d | $131.31 | 42,744 | direct | ||
ORDINARY SHARES | 2021-08-02 | A | 6,019 | a | $0.00 | 48,763 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 131.26 | 2021-08-02 | deemed execution date | A | 51,423 (a) | 2022-08-02 | 2031-08-02 | ordinary shares 51,423 | $131.26 | 51,423 | direct | |
STOCK OPTION (RIGHT TO BUY) | 131.26 | 2021-08-02 | deemed execution date | A | 1,085 (a) | 2022-08-02 | 2031-08-02 | ordinary shares 1,085 | $131.26 | 1,085 | direct | |
PERFORMANCE SHARE UNITS | 0.0 | 2021-08-02 | deemed execution date | A | 15,047 (a) | performance share units 15,047 | $0.00 | 15,047 | direct |
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan. |
f2 | this balance increased by 651 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. |
f3 | the restrictions on the award shall lapse 100% on the third anniversary of the grant date. |
f4 | these options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
f5 | each performance share unit represents a contingent right to receive one share of medtronic common stock. |
f6 | the number of shares to be issued in connection with the performance share units ("psus") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. if target performance metrics are achieved, 15,047 shares will be issued. the actual number of shares to be issued could range from a low of 3,010 at minimum performance to a high of 30,094 shares at maximum performance. if minimum performance metrics are not met, such psus may vest at 0 shares. |
f7 | vests on august 2, 2024. |